Please login to the form below

implant

This page shows the latest implant news and features for those working in and with pharma, biotech and healthcare.

FDA approves Allergan’s biodegradable glaucoma implant drug

Durysta (bimatoprost implant) is the first biodegradable, sustained-release implant for IOP in patients with open-angle glaucoma or ocular hypertension. ... As the first FDA-approved intracameral, biodegradable sustained-release implant providing

Latest news

Bayer bulks up in women’s health again with non-hormonal contraceptive deal

The German drugmaker is already a major player in the women’s health market, selling a range of contraceptive products including oral and injectable hormonal products and implants, and is one ... Bayer hasn’t had the happiest recent history in the
Servier faces manslaughter trial over weight loss drug deaths

from defective breast implants manufactured by Poly Implant Prothese (PIP).
HIV meeting hears progress towards vaccine and cure

Meanwhile, Merck &Co/MSD presented preliminary results with a new HIV drug – islatravir (MK-8591) – that it believes could offer a year of anti-HIV activity from a single implant, rather
Elon Musk’s NeuraLink applies to trial ‘brain-machine interface’

to surgically implant the threads that is “as simple and automated as LASIK” – the laser surgery commonly used for vision correction – and eventually might not even need anaesthesia. ... The basic concepts on offer at NeuraLink aren’t
CHMP nod for Alexion, GSK drugs, revocation for Lartruvo

Other drugs gaining recommendation included:. Molteni Farmaceutici’s Sixmo (buprenorphine) an opioid dependence implant treatment that releases low levels of buprenorphine into the patient’s body for six months.

More from news
Approximately 1 fully matching, plus 94 partially matching documents found.

Latest Intelligence

The transatlantic opioid crisis

such as the group litigation order (GLO) for silicone breast implants.
Delivering the promise of regenerative medicine

Once only imaginable in science fiction, the latest applications include engineered skin tissue to treat burns victims, custom-grown bones for implants and joint replacements, personalised dietary treatments using gut bacteria
Changes to look out for in Medical Devices Regulations

PIP. In 2000, it was discovered that Poly Implant Prothèse (PIP) had been using industrial-grade silicone instead of the medical-grade specified for the CE mark in the manufacture of ... The CE mark for PIP implants was consequently withdrawn, and
Tightening medical device safety

Building on the lessons learned from recent events (such as the French PIP breast implant scandal), the EU regulations require that each device bears a unique device identifier (UDI) and that ... In this regard, medical device users of implantable
Deal Watch - May 2017

its bupivacaine collagen implant for treatment of post-operative pain. ... Innocoll (US/IE). Gurnet Point (US). Company acquisition. Company with US pre-registration bupivacaine collagen implant for post-operative pain.

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

Promimic appoints CEO

Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development. ... Magnus brings valuable global leadership experience and a wide network from his time in the dental implant
Histogenics names former MedImmune president as CEO

This includes lead candidate NeoCart – a cartilage tissue implant in phase III trials.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Courageous Conversation ep.9: Elon Musk's Neuralink and the Future of the Computer Brain Interface

Natalie Yeadon, Co-Owner and Managing Director at Impetus Digital, provides insight on Elon Musk's Neuralink and the Future of the Computer Brain Interface. Address:. Impetus Digital. WaterPark Place. 20 Bay Street, 11th Floor. Toronto. Ontario. M5J
RWE Blog 1: Real-world challenges and real-world data

Greater improvement of key clinical outcomes in patients with diabetic macular oedema from a real-world study of a fluocinolone intravitreal implant, compared with the results of the FAME (Fluocinolone Acetonide

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

MEDICAL WRITER - HOME WORKING: Salary TBC

SENIOR MEDICAL WRITER: Salary TBC

ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER: Salary TBC

SENIOR ACCOUNT MANAGER - MEDICAL COMMUNICATIONS: Salary TBC

Senior Account Director - Med Comms Agency: Salary TBC

PMHub

Add my company

Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

Good design saves lives: Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies: Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
A cultural shift in clinical research: Research organisations across the board are experimenting with new technologies...